Objective: Angiotensin-converting enzyme (ACE) inhibitor and angiotensin II type I receptor blockers (ARB) prevent cardiac remodeling after myocardial infarction (MI). However, it is controversial whether combination therapy of ACE inhibitor and ARB is more effective on cardiac remodeling than each agent alone. In this study, we compared the effects of an ACE inhibitor (temocapril), an ARB (CS-866), and their combination on cardiac remodeling after MI. Methods: Temocapril at 3 or 30 mg / kg / day, CS-866 at 1 or 10 mg / kg / day, or combined temocapril and CS-866 at 1.5 and 0.5 mg / kg / day or at 15 and 5 mg / kg / day, respectively, were administered to rats after MI. At 4 weeks after MI, we assessed hemodynamics, cardiac function by Doppler echocardiography and non-infarcted myocardial mRNA expression. Results: Animals treated with a combination of the two drugs had hemodynamics, heart weights and dimensions similar to the other treated animals. However, the combination of the two drugs suppressed ANP, BNP and other gene expressions related to contractile proteins of fetal type and collagens more effectively than ACE inhibitor or ARB alone. Conclusion: These data suggest that combination of the two drugs, independent of the hemodynamic effect, may improve left ventricular phenotypic change, collagen accumulation and diastolic function.
Yasukatsu Izumi , Kazuhide Takeuchi , Shokei Kim , Hiroshi Iwao , Junichi Yoshikawa infarction LV remodeling [4, 5] and there is no difference in mg / kg / day and CS-866 5 mg / kg / day within 6 h after survival at 1 year between rats treated with ACE inhibitor coronary ligation. All drugs were orally given to MI rats or ARB [6] . Combined ACE inhibitor and ARB provides by gastric gavage once a day for 4 weeks after MI. We enhanced benefits in heart failure [7] . Recently, Mankad et used sham-operation rats as controls. We also administered al. showed that combination therapy with ACE inhibitor vehicle (0.5% carboxymethylcellulose solution) to myocarand ARB attenuates postinfarction left ventricular remodeldial infarcted rats. The vehicle-treated group was used for ing and systolic dysfunction in an ovine model [8] . On the obtaining specimens from animals that did not receive other hand, Taylor et al. reported that a combined therapy pharmacotherapy. of two drugs has no beneficial effect on postinfarction LV remodeling [9] .
2 .2. Doppler-echocardiographic studies and The purpose of this study was to examine the effect of physiological studies combination therapy with the two drugs on diastolic (as well as systolic) abnormalities determined by echocardiogTransthoracic echocardiographic studies were performed raphy and gene expression encoding proteins potentially as previously described in detail [5] . In brief, rats were implicated in the remodeling process after myocardial lightly anesthetized with intraperitoneal injection of infarction.
ketamine HCl and xylazine. Echocardiograms were performed using an echocardiographic system equipped with a 12.0-MHz phased-array transducer (SONOS 5500; Philips
. Methods
Medical System, Best, The Netherlands). Two-dimensional short-axis view of the left ventricle and M-mode tracings 2 .1. Dose-selection, experimental animals and protocol were recorded through the anterior and posterior LV walls at the papillary muscle level to measure LV end-diastolic The administration of CS-866 at 1 and 10 mg / kg / day to dimension (LVEDD). LV ejection fraction (LVEF) was cardiomyopathy hamsters resulted in an increase in cardiac measured by modified Simpson's method, which uses a HGF concentration and mRNA, and a decrease in cardiac 4-chamber view. Pulse-wave Doppler spectra (E and A collagen III mRNAs to the same extent [10] . Temocapril at waves velocity) of mitral inflow were recorded from the 1 and 10 mg / kg / day and CS-866 at 1 and 10 mg / kg / day apical 4-chamber view, with the sample volume placed could block cardiac remodeling-induced chronic inhibition near the tips of the mitral leaflets. All Doppler spectra were of NO synthesis [11] . However, in this model, the prevenrecorded on paper at 100 mm / s and analyzed off-line. tive effect of temocapril on cardiac hypertrophy is less
The method of hemodynamics measurement was previthan CS-866. On the other hand, we showed that temocapously described in detail [14] . In brief, LV pressure was ril at 3 mg / kg / day prevented left ventricular remodeling in recorded by inserting a polyethylene-tubing catheter (0.58-myocardial infarcted rats at the same level as candesartan mm internal diameter, PE-50) into the right carotid artery cilexitil (ARB) at 1 mg / kg / day [12] . Moreover, Higasiura and advancing it into the left ventricle. Water-filled catheet al. reported that both temocapril at 1 mg / kg / day and ters were connected to the tubing connected to a water-CS-866 at 0.3 mg / kg / day could modulate the muscle fiber filled pressure transducer. The pressures were recorded on composition in a hypertensive and insulin-resistant animal a physiological recorder, while rats were allowed to model to the same extent [13] . At the same dose, the effect breathe spontaneously. LV end-diastolic pressure (LVEDP) of CS-866 on cardiovascular disease may be about three was obtained by averaging the values for 10 beats. times stronger than temocapril. Therefore, in this study we Myocardial infarct size was measured as previously dechose temocapril at 3 and 30 mg / kg / day and CS-866 at 1 scribed [14] . Rats with an infarct size of ,30% were and 10 mg / kg / day for dose-selection. We used half the excluded from analysis because they did not show typical monotherapy dose of each in the combination therapy of LV remodeling. After determination of infarct size, the two drugs.
heart was immediately excised and septal myocardium was Male Wistar rats weighing 290 to 310 g were purchased dissected as non-infarcted myocardium. The specimens from Clea Japan (Osaka, Japan). MI was produced by were immediately frozen and stored at 280 8C until use. ligation of the left coronary artery as previously described [14] . The same surgical procedures were performed on a 2 .3. RNA preparation and Northern blot analysis control group of rats except that the suture around the coronary artery was not tied. Rats that survived after All procedures were performed as described in detail in coronary ligation were randomly divided into groups and our previous report [5] . In brief, total RNA was isolated treated with (1) vehicle (0.5% carboxymethylcellulose from septal myocardium by the guanidium thiocyanatesolution), (2) temocapril 3 mg / kg / day, (3) temocapril 30 phenol-chloroform method, and 20 mg of total RNA mg / kg / day, (4) CS-866 1 mg / kg / day, (5) CS-866 10 samples were subjected to 1% agarose gel electrophoresis, mg / kg / day, (6) combined temocapril 1.5 mg / kg / day and transferred to nylon membrane, and hybridization was 32 CS-866 0.5 mg / kg / day and (7) combined temocapril 15 carried out with ( P)-dCTP-labeled cDNA probe for atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), controls (P,0.01). Temocapril, CS-866 and their combinatransforming growth factor b1 (TGF-b1), collagen type I tion significantly reduced LVEDP post MI (P,0.01). and III, and glyceraldehyde-3-phosphate dehydrogenase
There was no significant difference in LVEDP among the 32 (GAPDH), or with (g-P)-ATP-labeled oligonucleotide treatment groups. LV weight, corrected for body weight for a-myosin heavy chain (a-MHC), b-myosin heavy (BW), in rats with MI was significantly reduced by all chain (b-MHC), a-skeletal actin (a-Ske A), and a-cardiac drug treatments (P,0.01). Right ventricular (RV) weight, actin (a-Car A). The densities of an individual mRNA corrected for BW, in rats with MI was significantly higher band were measured by using a bioimaging analyzer than that in controls (P,0.01). Compared with untreated (BAS-2000, Fuji Photo Film, Tokyo, Japan).
MI, RV weight was significantly reduced by temocapril at 3 mg/kg/day (P,0.05) and 30 mg / kg / day (P,0.01), and 2 .4. Statistics by CS-866 at 1 and 10 mg / kg / day (P,0.01). Combination treatment tended to reduce RV weight more than either Results were expressed as mean6S.E.M. Statistical agent alone. There was no significant difference in MI size significance was determined using ANOVA and Duncan's among the groups. multiple range test. Differences were considered statistically significant at P,0.05.
.2. Doppler echocardiographic assessment
Echocardiographic assessments of LV geometry and 3 . Results function at 4 weeks are shown in Table 2 . LV end-diastolic dimensions (LVDd) and LV end-diastolic volume 3 .1. Changes in hemodynamics and ventricular weight (LVEDV) significantly increased in vehicle rats with MI compared with control rats (P,0.01). Both LVDd and As shown in Table 1 , all drugs slightly, but not LVEDV in rats with MI was significantly reduced by all significantly, lowered mean blood pressure in rats with MI. drug treatment (P,0.01). Vehicle rats with MI had signifi-LVEDP was significantly higher in rats with MI than in cant systolic dysfunction, as evidenced by decreased LV ejection fraction (LVEF) compared with control rats (P, b-MHC, a-Ske A, ANP, BNP and TGF-b1, and collagen 0.01). LVEF in rats with MI was significantly improved by type I and III mRNA expression significantly increased all drug treatment (P,0.01). However, there was no (3.1-, 3.9-, 5.0-, 10.1-, 2.0-, 10.9-and 8.2-fold, respectivesignificant difference in LVDd, LVEDV and LVEF among ly, P,0.01) in the non-infarcted myocardium. Temocapril all treated groups. at 3 and 30 mg / kg / day, and CS-866 at 1 and 10 mg / kg / Examples of pulse-wave Doppler recordings of mitral day significantly attenuated the increased expression of inflow from the seven groups are shown in Fig. 1 .
b-MHC, a-Ske A, ANP, BNP, TGF-b1 and collagen type I Compared with the control group, MI group had significant and III mRNA (P,0.01). Moreover, the combination of diastolic dysfunction (P,0.01), as defined by increased ACE inhibitor and ARB was more effective than either early rapid filling wave (E wave) velocity, decreased late agent alone in attenuating expression of b-MHC, a-Ske A, filling wave due to atrial contraction (A-wave) velocity, an ANP, BNP (P,0.01), TGF-b1 and collagen type I and III increased ratio of E wave to A wave (E /A ratio) and a mRNA (P,0.05). Thus, the combination of ACE inhibitor decelerated E wave rate. All drug treatments significantly and ARB might prevent the increase in cardiac gene improved the diastolic function (P,0.01). Furthermore, expression after MI more than either agent alone. the improvement in diastolic function by combination of temocapril and CS-866 was significantly greater than that by any other drug treatments.
. Discussion

.3. Cardiac gene expression after myocardial infarction
Accumulating evidence suggests that the cardiac reninThe results of cardiac gene expression at 4 weeks are angiotensin system (RAS) is activated during the left shown in Fig. 2 and Table 3 . At 4 weeks after MI, ventricular (LV) remodeling process after acute myocardial Fig. 1 . Examples of pulse-wave Doppler spectra of mitral inflow from the sham operated rat (control), myocardial infarcted (MI) rat administered with vehicle, MI rat treated with temocapril at 3 or 30 mg / kg / day (ACEI (3) or ACEI (30), respectively), MI rat treated with CS-866 at 1 or 10 mg / kg / day (ARB (1) or ARB (10), respectively), the combination with temocapril at 1.5 and CS-866 at 0.5 mg / kg / day (ACEI (1.5)1ARB (0.5)), and the combination with temocapril at 5 and CS-866 at 15 mg / kg / day (ACEI (5)1ARB (15)). infarction (MI) [2, 14] . The result of the process may be and ARB are reported to have benefits beyond those of advanced LV systolic and diastolic dysfunction. Recently, either agent alone. A recent study shows that the combinaaccumulating evidence supports the notion that angiotensin tion of ACE inhibitor and ARB improves LV phenotypic II type I receptor blocker (ARB) has nearly the same change, increased LV collagen accumulation, diastolic favorable effects as ACE inhibitor on cardiac hypertrophy, dysfunction, and survival in rat heart failure model more remodeling and heart failure [5, 15, 16] . However, pharmaeffectively than either agent alone [19] . In the present cological profiles are substantially different between ARB study, we compared the effects of ACE inhibitor (temocapand ACE inhibitor, because ARB can inhibit the action of ril), ARB (CS-866), and a combination of these two agents angiotensin II (Ang II) generated through not only ACE assessed by Doppler echocardiography and cardiac gene but also alternative pathways of Ang II formation [17] , expression associated with cardiac remodeling in rats with whereas ACE inhibitors block bradykinin metabolism MI. We obtained important evidence that the combination [3, 18] . Therefore, combination therapy with ACE inhibitor of ACE inhibitor and ARB improves LV phenotypic change, increased LV collagen accumulation, and diastolic TGF-b1 may be responsible for the development of LV dysfunction in LV remodeling after MI.
remodeling [26] . Kim et al. reported that TGF-b1 mRNA Doppler echocardiography is currently the primary expression in cardiac hypertrophy of SHRSP is prevented technique for evaluating left ventricular diastolic function.
by ACE inhibitor or ARB [27] . In our study, a combinaIncreased E-wave velocity, decreased peak A-wave vetion therapy with ACE inhibitor and ARB prevented TGFlocity (or absent A wave), and rapid E-wave deceleration b1 mRNA expression as well as other mRNAs referred to were observed in our rats, and these flow patterns were as remodeling. similar to transmitral flow profiles observed in patients Solid evidence indicates that angiotensin II directly with heart failure with restrictive patterns. ACE inhibitor, stimulates LV ANP, BNP, TGF-b1, and collagen gene ARB and these agents in combination decreased the E /A expression via AT1 receptor independently of its hemoratio and E-wave deceleration rate. Long-term ACE inhibdynamic effect [28, 29] . Therefore, in the present study, the itor therapy could prevent changes in left ventricular mechanism underlying the greater suppression of LV ANP diastolic properties in patients with depressed ejection gene expression, TGF-b1, and collagen accumulation in fraction [20] . Improvement of diastolic filling pattern is myocardial infarcted rats by combined ACE inhibitor and caused by preload, afterload reduction, improvement in left ARB than either agent alone may be explained by a more ventricular relaxation, or decrease in passive elastic proppotent inhibition of angiotensin II-mediated AT1 receptor erties. Our data do not directly answer the question of activation itself. However, ACE inhibitor increases tissue whether the change in left ventricle filling patterns are due bradykinin accumulation, and the bradykinin has antigto changes in myocardial properties, changes in left rowth effects and reduces vasomotor tone [3] . Therefore, ventricle loading conditions, or both. The major limitation the possibility cannot be excluded that the accumulation of of diastolic assessment by echo-Doppler techniques lies in bradykinin by ACE inhibitor might have participated in the the load-dependency of the E and A waves and their ratio.
present beneficial effects of the combination therapy in When viewed in the context of previous studies using myocardial infarcted rats. Conversely, unlike ACEI, ARB isolated muscle preparations from the same animal model increases circulating angiotensin II levels, leading the of heart failure [21, 22] , the improvement in diastolic filling stimulation of AT2 receptor, which has antigrowth effects pattern that accompanies inhibition of the renin-angioten- [15, 30] . However, unlike treatment with ARB alone, the sin system results from a combination of effects on left combination with ACE inhibitor suppresses plasma anventricular preload and afterload as well as left ventricular giotensin II elevation induced by ARB, indicating that chamber properties. LVEDP was not statistically signifi-AT2 receptor activation caused by ARB alone is nullified cant between the treatment arms, however, improvement of by the combination with ACE inhibitor. Therefore, it is E /A waves ratio and E decelerations rate differed. This unlikely that AT2 receptor might have contributed to the means that a combination more effectively prevents an beneficial effects of the combination therapy in the present increase in left ventricular relaxation, a decrease in passive study. However, further work is needed to elucidate details elastic properties than each drug alone. Combination of the mechanism responsible for the beneficial effects of therapy with two agents may be a useful therapeutic the combination therapy on LV remodeling. strategy for treatment of diastolic dysfunction. Animals
We excluded infarcts ,30% of ventricular myocardium treated with a combination of the two drugs had hemofrom the analysis. The reason is that we can easily present dynamics, heart weights and dimensions similar to the the difference of the drug effect on the remodeling change, other treated animals. The combination of the two drugs the extent of which is related to infarct size. However, the suppressed ANP, BNP gene expressions, and other gene majority of both clinical and experimental infarcts are in expressions related to contractile proteins of fetal type and the range of 20-30%. Our myocardial infarcted rat model collagens more effectively than ACE inhibitor or ARB is a large size of myocardial infarction. Therefore, it is not alone. These data suggest that combination of the two certain whether our combination therapy is useful for drugs, independent of the hemodynamic effect, may immyocardial infarction in general. We missed having a prove left ventricular phenotypic change, collagen accumuuseful 'bench-to-bedside' value in our experiments. lation and diastolic function. We suppose that the combina-
In conclusion, we obtained important evidence that a tion of these two agents is more beneficial than monocombination of ACE inhibitor and ARB improves LV therapy for prevention of left ventricular remodeling.
phenotypic change, increased LV collagen accumulation, TGF-b1 appears to cause cellular hypertrophy and and diastolic dysfunction in LV remodeling after MI. stimulate the production of ECM such as fibronectin, collagen and laminin [23, 24] . Furthermore, the addition of TGF-b1 to cultured cardiac myocytes leads to the pheno-A cknowledgements typic modulation of myocytes, as shown by the induction of the gene expression of fetal contractile proteins [25] .
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